TAKE A LOOK AT WHICH REPORT YOUR PORTFOLIO'S BEEN MISSING...

Shareholders Foundation offers real-time reporting of class action exposure on a per transaction basis,
including the documents you will need for claim filing and settlement recovery.
Start Monitoring Your Investments

Pernix Therapeutics Holdings Inc (NASDAQ:PTX) Investor Investigation Over Possible Breaches Of Fiduciary Duties Announced

  • If you purchased shares of Pernix Therapeutics Holdings Inc (NASDAQ:PTX), you have certain options and you should contact the Shareholders Foundation, Inc.

  • To have your information reviewed for options and to receive notifications about this investigation, please send an email to mail@shareholdersfoundation.com, or call us at (858) 779-1554.

Investigation Overview

Company
Pernix Therapeutics Holdings Inc
Security
NASDAQ: PTX

Summary

October 14, 2015 (Shareholders Foundation) - An investigation on behalf of current long-term investors in shares of Pernix Therapeutics Holdings Inc (NASDAQ:PTX) shares was announced over potential breaches of fiduciary duties by certain officers and directors at Pernix Therapeutics Holdings Inc.

The investigation by a law firm concerns whether certain Pernix Therapeutics Holdings officers and directors breached their fiduciary duties and caused damage to the company and its shareholders.

Pernix Therapeutics Holdings Inc reported that its annual Total Revenue rose from $84.87 million in 2013 to $121.75 million in 2014 and that its Net Loss increased from $25.64 million to $35.29 million.

Shares of Pernix Therapeutics Holdings Inc (NASDAQ:PTX) declined from $11.89 per share in March 2015 to as low as $11.91 per share on September 29, 2015.

On October 14, 2105, NASDAQ:PTX shares closed at $3.24 per share.

Start Monitoring Your Investments